Evaluation and Management of Spastic Gait in Patients with Traumatic Brain Injury

Journal of Head Trauma Rehabilitation

Volumn 19, Issue 2, 2004, Pages 109-118

  Esquenazi, Alberto ^a  

^a MOSS REHABILITATION RESEARCH INSTITUTE   (United States)

Author keywords

Gait; Spasticity traumatic brain injury; Upper motoneuron syndrome

Indexed keywords

BOTULINUM TOXIN A; PHENOL;

ALGORITHM; BRAIN INJURY; CLINICAL EXAMINATION; DAILY LIFE ACTIVITY; DISEASE COURSE; ELECTROMYOGRAPHY; FUNCTIONAL DISEASE; GAIT; HUMAN; KINEMATICS; KNEE FUNCTION; MEDICAL DECISION MAKING; MOBILIZATION; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MUSCLE CONTRACTURE; MUSCLE STIFFNESS; NERVE BLOCK; NEUROLYSIS; PATIENT MONITORING; PYRAMIDAL TRACT; REVIEW; SPASTICITY; TREATMENT PLANNING; VERBAL COMMUNICATION; VOLUNTARY MOVEMENT;

EID: 1842433728     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-200403000-00004     Document Type: Review

References (14)

1. Farmer SF, Swash M, Ingram DA, et al. Changes in motor unit synchronization following central nervous lesions in man. J Physiol (Lond). 1993;463:83-105.
2. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner. 1964;192:540.
3. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago: Year Book Medical Publisher; 1980.
4. Campbell SK. Framework for the measurement of neurological impairment in disability. In: Wyster MJ, ed. Contemporary Management of Motor Control Problems. Proceedings of the II Step Conference. Alexandria Va: Foundation for Physical Therapy; 1991;146-147.
5. Mayer N, Esquenazi A, Childers M. Common patterns of clinical motor dysfunction. Muscle Nerve. 1997;(suppl 6):S21-S35.
6. Mayer NH, Esquenazi A, Keenan MAE. Patterns of upper motoneuron dysfunction in the lower limb. In: Ruzicka E, Hallet M, Jankovic J, eds. Vol 87. Gait Disorders, Advances in Neurology. Philadelphia: Lippincot; 2001:311-319.
7. Mayer N. Choosing upper limb muscles for focal intervention after traumatic brain injury. J Head Trauma Rehabil. 2004;19(2):119-142.
8. Esquenazi A, Hirai B. Gait analysis in stroke and head injury. In: Craik, Oatis, eds. Gait Analysis, Theory and Application. St. Louis: Mosby; 1995;412-419.
9. Jankovic J, Schwartz K. Clinical correlates of response to botulinum toxin injections. Arch Neurol. 1991;48:1253-1256.
10. Koman LA, Mooney J, Smith B, Goodman A. Cerebral palsy management by neuromuscular blockade with Botulinum-A Toxin. In: NIH Consensus Development Conference on Clinical Use of Botulinum Toxin; November 1990; Bethesda, Md.
11. Mayer N, Esquenazi A, Keenan MAE. Analysis and management of spasticity, contracture and impaired motor control. In: Horn L, Zasler N, eds. Medical Rehabilitation of Traumatic Brain Injury. Philadelphia: Henley & Belfus; 1996;411-458.
12. Esquenazi A, Keenan MA. Normal and pathologic gait. In: Delisa's Rehabilitation Medicine: Principles and Practice. 2nd ed. Philadelphia: Lippincott; 1993.
13. Fuller DA, Keenan MA, Esquenazi A, Whyte J, Mayer N, Fidler-Sheppard R. The impact of instrumented gait analysis on surgical planing: treatment of spastic equinovarus deformity of the foot and ankle. Foot Ankle Int. August 2002;22:738-743.
14. Brin M, Childers M, Esquenazi A, et al. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset-spasticity. Muscle Nerve. 1997;(Suppl 6):S208-S220.